Literature DB >> 29050940

Long non-coding RNA-422 acts as a tumor suppressor in colorectal cancer.

Qianwen Shao1, Jing Xu2, Rong Deng3, Wei Wei3, Bing Zhou3, Chao Yue3, Miaoling Zhu4, Xingen Huang5, Haitao Zhu6.   

Abstract

Colorectal cancer (CRC) is one of the most frequent cancer in numerous of countries worldwidely. The initiation and progression of CRC is an extremely complex process, and have been suggested a correlation with Long non-coding RNAs (lncRNAs). Our results showed that lncRNA-422(ENST00000415820) significantly downregulated in the tissues and serum of CRC patients, and is closely associated with the poor prognosis. Then gain or loss of lncRNA-422 models in SW480 and SW620cells were established. The results showed that lncRNA-422 overexpression inhibited cell proliferation, migration, and invasion. Knockdown of lncRNA-422 promoted tumorigensis. Western blot and qRT-PCR were performed to examine the activity of the PI3K/AKT/mTOR pathway in CRC cells after alternation of lncRNA-422. Results showed that lncRNA-422 acts as a tumor suppressor by PI3K/AKT/mTOR pathway in CRC.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; Colorectal cancer; PI3K/AKT/mTOR; Proliferation; lncRNA-422

Mesh:

Substances:

Year:  2017        PMID: 29050940     DOI: 10.1016/j.bbrc.2017.10.076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Epidrugs: targeting epigenetic marks in cancer treatment.

Authors:  Cristiana Libardi Miranda Furtado; Maria Claudia Dos Santos Luciano; Renan Da Silva Santos; Gilvan Pessoa Furtado; Manoel Odorico Moraes; Claudia Pessoa
Journal:  Epigenetics       Date:  2019-07-13       Impact factor: 4.528

Review 2.  Targeting PI3K in cancer: mechanisms and advances in clinical trials.

Authors:  Jing Yang; Ji Nie; Xuelei Ma; Yuquan Wei; Yong Peng; Xiawei Wei
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

3.  Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.

Authors:  Anquan Shang; Weiwei Wang; Chenzheng Gu; Wei Chen; Wenying Lu; Zujun Sun; Dong Li
Journal:  Aging (Albany NY)       Date:  2020-05-07       Impact factor: 5.682

4.  LncRNA-422 suppresses the proliferation and growth of colorectal cancer cells by targeting SFPQ.

Authors:  Yixuan Meng; Shuwei Li; Qiuyi Zhang; Shuai Ben; Qiuyuan Zhu; Mulong Du; Dongying Gu
Journal:  Clin Transl Med       Date:  2022-01

5.  LncRNA-ENST00000543604 exerts a tumor-promoting effect via miRNA 564/AEG-1 or ZNF326/EMT and predicts the prognosis of and chemotherapeutic effect in colorectal cancer.

Authors:  Weimin Wang; Zhen Zhou; Xiaojun Dai; Haibo Wang; Jun Jin; Ke Min; Yunfan Wang; Mengying Lv; Yanqing Liu; Yan Zhou
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.